Trudy Lieberman, Community Health News ServiceHow soon will there be a vaccine to protect people from the coronavirus? That’s the question uppermost on the minds of many Americans, especially the elderly and others especially at risk for a severe bout of the disease. Everyone wants the vaccine yesterday. Maybe that’s why the media cheered in late May and hope soared when Moderna, a 10-year-old biotechnology company based in Cambridge, Massachusetts, issued a news release with hopeful information.Positive Phase 1 data, although early, showed promising results, the company said: “These data substantiate our belief that mRNA-1273 (the vaccine name) has potential to prevent COVID-19 disease.”Given how devastating the disease has been, who wouldn’t appreciate news like th
